BlackRock’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $77.2M | Buy |
4,423,464
+124,476
| +3% | +$2.17M | ﹤0.01% | 2190 |
|
|
2025
Q1 | $54.1M | Sell |
4,298,988
-275,503
| -6% | -$3.47M | ﹤0.01% | 2312 |
|
|
2024
Q4 | $48.3M | Buy |
4,574,491
+328,517
| +8% | +$3.47M | ﹤0.01% | 2439 |
|
|
2024
Q3 | $61.6M | Buy |
4,245,974
+161,635
| +4% | +$2.34M | ﹤0.01% | 2322 |
|
|
2024
Q2 | $34.8M | Buy |
4,084,339
+1,426,100
| +54% | +$12.1M | ﹤0.01% | 2599 |
|
|
2024
Q1 | $27.2M | Buy |
2,658,239
+20,690
| +0.8% | +$211K | ﹤0.01% | 2763 |
|
|
2023
Q4 | $14.5M | Buy |
2,637,549
+70,765
| +3% | +$388K | ﹤0.01% | 3133 |
|
|
2023
Q3 | $9.7M | Buy |
2,566,784
+305,864
| +14% | +$1.16M | ﹤0.01% | 3300 |
|
|
2023
Q2 | $15.1M | Buy |
2,260,920
+1,142,355
| +102% | +$7.65M | ﹤0.01% | 3132 |
|
|
2023
Q1 | $7.28M | Buy |
1,118,565
+215,020
| +24% | +$1.4M | ﹤0.01% | 3399 |
|
|
2022
Q4 | $7.71M | Buy |
903,545
+175,841
| +24% | +$1.5M | ﹤0.01% | 3447 |
|
|
2022
Q3 | $3.84M | Buy |
727,704
+19,859
| +3% | +$105K | ﹤0.01% | 3796 |
|
|
2022
Q2 | $3M | Sell |
707,845
-899,655
| -56% | -$3.81M | ﹤0.01% | 3977 |
|
|
2022
Q1 | $5.64M | Buy |
1,607,500
+28,213
| +2% | +$99K | ﹤0.01% | 3817 |
|
|
2021
Q4 | $10.5M | Buy |
1,579,287
+351,626
| +29% | +$2.34M | ﹤0.01% | 3580 |
|
|
2021
Q3 | $12.3M | Buy |
1,227,661
+348,296
| +40% | +$3.48M | ﹤0.01% | 3527 |
|
|
2021
Q2 | $27.2M | Sell |
879,365
-339,903
| -28% | -$10.5M | ﹤0.01% | 3066 |
|
|
2021
Q1 | $53.2M | Buy |
1,219,268
+829,107
| +213% | +$36.2M | ﹤0.01% | 2533 |
|
|
2020
Q4 | $18.1M | Buy |
+390,161
| New | +$18.1M | ﹤0.01% | 2996 |
|